Global Ophthalmology Disorders Drug Market Growth (Status and Outlook) 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Ophthalmology Disorders Drug will have significant change from previous year. According to our (LP Information) latest study, the global Ophthalmology Disorders Drug market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Ophthalmology Disorders Drug market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Ophthalmology Disorders Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Ophthalmology Disorders Drug market, reaching US$ million by the year 2028. As for the Europe Ophthalmology Disorders Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Ophthalmology Disorders Drug players cover Sanofi, Bayer, Bausch + Lomb, and Novartis, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Ophthalmology Disorders Drug market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
As the global economy mends, the 2021 growth of Ophthalmology Disorders Drug will have significant change from previous year. According to our (LP Information) latest study, the global Ophthalmology Disorders Drug market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Ophthalmology Disorders Drug market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Ophthalmology Disorders Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Ophthalmology Disorders Drug market, reaching US$ million by the year 2028. As for the Europe Ophthalmology Disorders Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Ophthalmology Disorders Drug players cover Sanofi, Bayer, Bausch + Lomb, and Novartis, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Ophthalmology Disorders Drug market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
- Oral
- Injection
- External Use
- Juvenile Macular Degeneration (Stargardt Disease)
- Leber Congenital Amaurosis (LCA)
- Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)
- Usher Syndrome
- Retinitis Pigmentosa (Retinitis)
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi
- Bayer
- Bausch + Lomb
- Novartis
- Usher Syndrome
- Takeda Pharmaceutical
- Roche
- Pfizer
- Allergan
- Gilead Sciences
- Kubota Pharmaceutical
- Alkeus Pharmaceuticals
- Astellas Pharma
- Ferrer Corporate
- Amgen Inc
- Editas Medicine Inc
- ProQR Therapeutics NV
- ReNeuron
- Amarantus BioScience
- Ocugen
- ReGenX Biosciences
- Sucampo Pharmaceuticals
- Orphagen Pharmaceuticals
- Okuvision
- Second Sight Medical
- Acucela
- Stealth BioTherapeutics
- Sun Pharma Advanced Research Company
- AmpliPhi Biosciences
- Applied Genetic Technologies
- Asklepios BioPharmaceutical
- Biovista
- Spark Therapeutics
- Caladrius Biosciences
- Dompe Farmaceutici
- Dormant Projects
- Grupo Ferrer Internacional
- ID Pharma
- InFlectis BioScience
- Ionis Pharmaceuticals
- Ixchel Pharma
- Khondrion
- Mimetogen Pharmaceuticals
- Mitotech
- M's Science
- Nanovector
- SanBio
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Ophthalmology Disorders Drug Market Size 2017-2028
2.1.2 Ophthalmology Disorders Drug Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Ophthalmology Disorders Drug Segment by Type
2.2.1 Oral
2.2.2 Injection
2.2.3 External Use
2.3 Ophthalmology Disorders Drug Market Size by Type
2.3.1 Ophthalmology Disorders Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Ophthalmology Disorders Drug Market Size Market Share by Type (2017-2022)
2.4 Ophthalmology Disorders Drug Segment by Application
2.4.1 Juvenile Macular Degeneration (Stargardt Disease)
2.4.2 Leber Congenital Amaurosis (LCA)
2.4.3 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)
2.4.4 Usher Syndrome
2.4.5 Retinitis Pigmentosa (Retinitis)
2.5 Ophthalmology Disorders Drug Market Size by Application
2.5.1 Ophthalmology Disorders Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Ophthalmology Disorders Drug Market Size Market Share by Application (2017-2022)
3 OPHTHALMOLOGY DISORDERS DRUG MARKET SIZE BY PLAYER
3.1 Ophthalmology Disorders Drug Market Size Market Share by Players
3.1.1 Global Ophthalmology Disorders Drug Revenue by Players (2020-2022)
3.1.2 Global Ophthalmology Disorders Drug Revenue Market Share by Players (2020-2022)
3.2 Global Ophthalmology Disorders Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 OPHTHALMOLOGY DISORDERS DRUG BY REGIONS
4.1 Ophthalmology Disorders Drug Market Size by Regions (2017-2022)
4.2 Americas Ophthalmology Disorders Drug Market Size Growth (2017-2022)
4.3 APAC Ophthalmology Disorders Drug Market Size Growth (2017-2022)
4.4 Europe Ophthalmology Disorders Drug Market Size Growth (2017-2022)
4.5 Middle East & Africa Ophthalmology Disorders Drug Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Ophthalmology Disorders Drug Market Size by Country (2017-2022)
5.2 Americas Ophthalmology Disorders Drug Market Size by Type (2017-2022)
5.3 Americas Ophthalmology Disorders Drug Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ophthalmology Disorders Drug Market Size by Region (2017-2022)
6.2 APAC Ophthalmology Disorders Drug Market Size by Type (2017-2022)
6.3 APAC Ophthalmology Disorders Drug Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Ophthalmology Disorders Drug by Country (2017-2022)
7.2 Europe Ophthalmology Disorders Drug Market Size by Type (2017-2022)
7.3 Europe Ophthalmology Disorders Drug Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Ophthalmology Disorders Drug by Region (2017-2022)
8.2 Middle East & Africa Ophthalmology Disorders Drug Market Size by Type (2017-2022)
8.3 Middle East & Africa Ophthalmology Disorders Drug Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL OPHTHALMOLOGY DISORDERS DRUG MARKET FORECAST
10.1 Global Ophthalmology Disorders Drug Forecast by Regions (2023-2028)
10.1.1 Global Ophthalmology Disorders Drug Forecast by Regions (2023-2028)
10.1.2 Americas Ophthalmology Disorders Drug Forecast
10.1.3 APAC Ophthalmology Disorders Drug Forecast
10.1.4 Europe Ophthalmology Disorders Drug Forecast
10.1.5 Middle East & Africa Ophthalmology Disorders Drug Forecast
10.2 Americas Ophthalmology Disorders Drug Forecast by Country (2023-2028)
10.2.1 United States Ophthalmology Disorders Drug Market Forecast
10.2.2 Canada Ophthalmology Disorders Drug Market Forecast
10.2.3 Mexico Ophthalmology Disorders Drug Market Forecast
10.2.4 Brazil Ophthalmology Disorders Drug Market Forecast
10.3 APAC Ophthalmology Disorders Drug Forecast by Region (2023-2028)
10.3.1 China Ophthalmology Disorders Drug Market Forecast
10.3.2 Japan Ophthalmology Disorders Drug Market Forecast
10.3.3 Korea Ophthalmology Disorders Drug Market Forecast
10.3.4 Southeast Asia Ophthalmology Disorders Drug Market Forecast
10.3.5 India Ophthalmology Disorders Drug Market Forecast
10.3.6 Australia Ophthalmology Disorders Drug Market Forecast
10.4 Europe Ophthalmology Disorders Drug Forecast by Country (2023-2028)
10.4.1 Germany Ophthalmology Disorders Drug Market Forecast
10.4.2 France Ophthalmology Disorders Drug Market Forecast
10.4.3 UK Ophthalmology Disorders Drug Market Forecast
10.4.4 Italy Ophthalmology Disorders Drug Market Forecast
10.4.5 Russia Ophthalmology Disorders Drug Market Forecast
10.5 Middle East & Africa Ophthalmology Disorders Drug Forecast by Region (2023-2028)
10.5.1 Egypt Ophthalmology Disorders Drug Market Forecast
10.5.2 South Africa Ophthalmology Disorders Drug Market Forecast
10.5.3 Israel Ophthalmology Disorders Drug Market Forecast
10.5.4 Turkey Ophthalmology Disorders Drug Market Forecast
10.5.5 GCC Countries Ophthalmology Disorders Drug Market Forecast
10.6 Global Ophthalmology Disorders Drug Forecast by Type (2023-2028)
10.7 Global Ophthalmology Disorders Drug Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Ophthalmology Disorders Drug Product Offered
11.1.3 Sanofi Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 Bayer
11.2.1 Bayer Company Information
11.2.2 Bayer Ophthalmology Disorders Drug Product Offered
11.2.3 Bayer Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Bayer Main Business Overview
11.2.5 Bayer Latest Developments
11.3 Bausch + Lomb
11.3.1 Bausch + Lomb Company Information
11.3.2 Bausch + Lomb Ophthalmology Disorders Drug Product Offered
11.3.3 Bausch + Lomb Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Bausch + Lomb Main Business Overview
11.3.5 Bausch + Lomb Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Ophthalmology Disorders Drug Product Offered
11.4.3 Novartis Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Usher Syndrome
11.5.1 Usher Syndrome Company Information
11.5.2 Usher Syndrome Ophthalmology Disorders Drug Product Offered
11.5.3 Usher Syndrome Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Usher Syndrome Main Business Overview
11.5.5 Usher Syndrome Latest Developments
11.6 Takeda Pharmaceutical
11.6.1 Takeda Pharmaceutical Company Information
11.6.2 Takeda Pharmaceutical Ophthalmology Disorders Drug Product Offered
11.6.3 Takeda Pharmaceutical Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Takeda Pharmaceutical Main Business Overview
11.6.5 Takeda Pharmaceutical Latest Developments
11.7 Roche
11.7.1 Roche Company Information
11.7.2 Roche Ophthalmology Disorders Drug Product Offered
11.7.3 Roche Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Roche Main Business Overview
11.7.5 Roche Latest Developments
11.8 Pfizer
11.8.1 Pfizer Company Information
11.8.2 Pfizer Ophthalmology Disorders Drug Product Offered
11.8.3 Pfizer Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Pfizer Main Business Overview
11.8.5 Pfizer Latest Developments
11.9 Allergan
11.9.1 Allergan Company Information
11.9.2 Allergan Ophthalmology Disorders Drug Product Offered
11.9.3 Allergan Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Allergan Main Business Overview
11.9.5 Allergan Latest Developments
11.10 Gilead Sciences
11.10.1 Gilead Sciences Company Information
11.10.2 Gilead Sciences Ophthalmology Disorders Drug Product Offered
11.10.3 Gilead Sciences Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Gilead Sciences Main Business Overview
11.10.5 Gilead Sciences Latest Developments
11.11 Kubota Pharmaceutical
11.11.1 Kubota Pharmaceutical Company Information
11.11.2 Kubota Pharmaceutical Ophthalmology Disorders Drug Product Offered
11.11.3 Kubota Pharmaceutical Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Kubota Pharmaceutical Main Business Overview
11.11.5 Kubota Pharmaceutical Latest Developments
11.12 Alkeus Pharmaceuticals
11.12.1 Alkeus Pharmaceuticals Company Information
11.12.2 Alkeus Pharmaceuticals Ophthalmology Disorders Drug Product Offered
11.12.3 Alkeus Pharmaceuticals Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Alkeus Pharmaceuticals Main Business Overview
11.12.5 Alkeus Pharmaceuticals Latest Developments
11.13 Astellas Pharma
11.13.1 Astellas Pharma Company Information
11.13.2 Astellas Pharma Ophthalmology Disorders Drug Product Offered
11.13.3 Astellas Pharma Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Astellas Pharma Main Business Overview
11.13.5 Astellas Pharma Latest Developments
11.14 Ferrer Corporate
11.14.1 Ferrer Corporate Company Information
11.14.2 Ferrer Corporate Ophthalmology Disorders Drug Product Offered
11.14.3 Ferrer Corporate Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Ferrer Corporate Main Business Overview
11.14.5 Ferrer Corporate Latest Developments
11.15 Amgen Inc
11.15.1 Amgen Inc Company Information
11.15.2 Amgen Inc Ophthalmology Disorders Drug Product Offered
11.15.3 Amgen Inc Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Amgen Inc Main Business Overview
11.15.5 Amgen Inc Latest Developments
11.16 Editas Medicine Inc
11.16.1 Editas Medicine Inc Company Information
11.16.2 Editas Medicine Inc Ophthalmology Disorders Drug Product Offered
11.16.3 Editas Medicine Inc Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Editas Medicine Inc Main Business Overview
11.16.5 Editas Medicine Inc Latest Developments
11.17 ProQR Therapeutics NV
11.17.1 ProQR Therapeutics NV Company Information
11.17.2 ProQR Therapeutics NV Ophthalmology Disorders Drug Product Offered
11.17.3 ProQR Therapeutics NV Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 ProQR Therapeutics NV Main Business Overview
11.17.5 ProQR Therapeutics NV Latest Developments
11.18 ReNeuron
11.18.1 ReNeuron Company Information
11.18.2 ReNeuron Ophthalmology Disorders Drug Product Offered
11.18.3 ReNeuron Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 ReNeuron Main Business Overview
11.18.5 ReNeuron Latest Developments
11.19 Amarantus BioScience
11.19.1 Amarantus BioScience Company Information
11.19.2 Amarantus BioScience Ophthalmology Disorders Drug Product Offered
11.19.3 Amarantus BioScience Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 Amarantus BioScience Main Business Overview
11.19.5 Amarantus BioScience Latest Developments
11.20 Ocugen
11.20.1 Ocugen Company Information
11.20.2 Ocugen Ophthalmology Disorders Drug Product Offered
11.20.3 Ocugen Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 Ocugen Main Business Overview
11.20.5 Ocugen Latest Developments
11.21 ReGenX Biosciences
11.21.1 ReGenX Biosciences Company Information
11.21.2 ReGenX Biosciences Ophthalmology Disorders Drug Product Offered
11.21.3 ReGenX Biosciences Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.21.4 ReGenX Biosciences Main Business Overview
11.21.5 ReGenX Biosciences Latest Developments
11.22 Sucampo Pharmaceuticals
11.22.1 Sucampo Pharmaceuticals Company Information
11.22.2 Sucampo Pharmaceuticals Ophthalmology Disorders Drug Product Offered
11.22.3 Sucampo Pharmaceuticals Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.22.4 Sucampo Pharmaceuticals Main Business Overview
11.22.5 Sucampo Pharmaceuticals Latest Developments
11.23 Orphagen Pharmaceuticals
11.23.1 Orphagen Pharmaceuticals Company Information
11.23.2 Orphagen Pharmaceuticals Ophthalmology Disorders Drug Product Offered
11.23.3 Orphagen Pharmaceuticals Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.23.4 Orphagen Pharmaceuticals Main Business Overview
11.23.5 Orphagen Pharmaceuticals Latest Developments
11.24 Okuvision
11.24.1 Okuvision Company Information
11.24.2 Okuvision Ophthalmology Disorders Drug Product Offered
11.24.3 Okuvision Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.24.4 Okuvision Main Business Overview
11.24.5 Okuvision Latest Developments
11.25 Second Sight Medical
11.25.1 Second Sight Medical Company Information
11.25.2 Second Sight Medical Ophthalmology Disorders Drug Product Offered
11.25.3 Second Sight Medical Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.25.4 Second Sight Medical Main Business Overview
11.25.5 Second Sight Medical Latest Developments
11.26 Acucela
11.26.1 Acucela Company Information
11.26.2 Acucela Ophthalmology Disorders Drug Product Offered
11.26.3 Acucela Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.26.4 Acucela Main Business Overview
11.26.5 Acucela Latest Developments
11.27 Stealth BioTherapeutics
11.27.1 Stealth BioTherapeutics Company Information
11.27.2 Stealth BioTherapeutics Ophthalmology Disorders Drug Product Offered
11.27.3 Stealth BioTherapeutics Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.27.4 Stealth BioTherapeutics Main Business Overview
11.27.5 Stealth BioTherapeutics Latest Developments
11.28 Sun Pharma Advanced Research Company
11.28.1 Sun Pharma Advanced Research Company Company Information
11.28.2 Sun Pharma Advanced Research Company Ophthalmology Disorders Drug Product Offered
11.28.3 Sun Pharma Advanced Research Company Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.28.4 Sun Pharma Advanced Research Company Main Business Overview
11.28.5 Sun Pharma Advanced Research Company Latest Developments
11.29 AmpliPhi Biosciences
11.29.1 AmpliPhi Biosciences Company Information
11.29.2 AmpliPhi Biosciences Ophthalmology Disorders Drug Product Offered
11.29.3 AmpliPhi Biosciences Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.29.4 AmpliPhi Biosciences Main Business Overview
11.29.5 AmpliPhi Biosciences Latest Developments
11.30 Applied Genetic Technologies
11.30.1 Applied Genetic Technologies Company Information
11.30.2 Applied Genetic Technologies Ophthalmology Disorders Drug Product Offered
11.30.3 Applied Genetic Technologies Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.30.4 Applied Genetic Technologies Main Business Overview
11.30.5 Applied Genetic Technologies Latest Developments
11.31 Asklepios BioPharmaceutical
11.31.1 Asklepios BioPharmaceutical Company Information
11.31.2 Asklepios BioPharmaceutical Ophthalmology Disorders Drug Product Offered
11.31.3 Asklepios BioPharmaceutical Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.31.4 Asklepios BioPharmaceutical Main Business Overview
11.31.5 Asklepios BioPharmaceutical Latest Developments
11.32 Biovista
11.32.1 Biovista Company Information
11.32.2 Biovista Ophthalmology Disorders Drug Product Offered
11.32.3 Biovista Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.32.4 Biovista Main Business Overview
11.32.5 Biovista Latest Developments
11.33 Spark Therapeutics
11.33.1 Spark Therapeutics Company Information
11.33.2 Spark Therapeutics Ophthalmology Disorders Drug Product Offered
11.33.3 Spark Therapeutics Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.33.4 Spark Therapeutics Main Business Overview
11.33.5 Spark Therapeutics Latest Developments
11.34 Caladrius Biosciences
11.34.1 Caladrius Biosciences Company Information
11.34.2 Caladrius Biosciences Ophthalmology Disorders Drug Product Offered
11.34.3 Caladrius Biosciences Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.34.4 Caladrius Biosciences Main Business Overview
11.34.5 Caladrius Biosciences Latest Developments
11.35 Dompe Farmaceutici
11.35.1 Dompe Farmaceutici Company Information
11.35.2 Dompe Farmaceutici Ophthalmology Disorders Drug Product Offered
11.35.3 Dompe Farmaceutici Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.35.4 Dompe Farmaceutici Main Business Overview
11.35.5 Dompe Farmaceutici Latest Developments
11.36 Dormant Projects
11.36.1 Dormant Projects Company Information
11.36.2 Dormant Projects Ophthalmology Disorders Drug Product Offered
11.36.3 Dormant Projects Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.36.4 Dormant Projects Main Business Overview
11.36.5 Dormant Projects Latest Developments
11.37 Grupo Ferrer Internacional
11.37.1 Grupo Ferrer Internacional Company Information
11.37.2 Grupo Ferrer Internacional Ophthalmology Disorders Drug Product Offered
11.37.3 Grupo Ferrer Internacional Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.37.4 Grupo Ferrer Internacional Main Business Overview
11.37.5 Grupo Ferrer Internacional Latest Developments
11.38 ID Pharma
11.38.1 ID Pharma Company Information
11.38.2 ID Pharma Ophthalmology Disorders Drug Product Offered
11.38.3 ID Pharma Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.38.4 ID Pharma Main Business Overview
11.38.5 ID Pharma Latest Developments
11.39 InFlectis BioScience
11.39.1 InFlectis BioScience Company Information
11.39.2 InFlectis BioScience Ophthalmology Disorders Drug Product Offered
11.39.3 InFlectis BioScience Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.39.4 InFlectis BioScience Main Business Overview
11.39.5 InFlectis BioScience Latest Developments
11.40 Ionis Pharmaceuticals
11.40.1 Ionis Pharmaceuticals Company Information
11.40.2 Ionis Pharmaceuticals Ophthalmology Disorders Drug Product Offered
11.40.3 Ionis Pharmaceuticals Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.40.4 Ionis Pharmaceuticals Main Business Overview
11.40.5 Ionis Pharmaceuticals Latest Developments
11.41 Ixchel Pharma
11.42 Khondrion
11.43 Mimetogen Pharmaceuticals
11.44 Mitotech
11.45 M's Science
11.46 Nanovector
11.47 SanBio
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Ophthalmology Disorders Drug Market Size 2017-2028
2.1.2 Ophthalmology Disorders Drug Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Ophthalmology Disorders Drug Segment by Type
2.2.1 Oral
2.2.2 Injection
2.2.3 External Use
2.3 Ophthalmology Disorders Drug Market Size by Type
2.3.1 Ophthalmology Disorders Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Ophthalmology Disorders Drug Market Size Market Share by Type (2017-2022)
2.4 Ophthalmology Disorders Drug Segment by Application
2.4.1 Juvenile Macular Degeneration (Stargardt Disease)
2.4.2 Leber Congenital Amaurosis (LCA)
2.4.3 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)
2.4.4 Usher Syndrome
2.4.5 Retinitis Pigmentosa (Retinitis)
2.5 Ophthalmology Disorders Drug Market Size by Application
2.5.1 Ophthalmology Disorders Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Ophthalmology Disorders Drug Market Size Market Share by Application (2017-2022)
3 OPHTHALMOLOGY DISORDERS DRUG MARKET SIZE BY PLAYER
3.1 Ophthalmology Disorders Drug Market Size Market Share by Players
3.1.1 Global Ophthalmology Disorders Drug Revenue by Players (2020-2022)
3.1.2 Global Ophthalmology Disorders Drug Revenue Market Share by Players (2020-2022)
3.2 Global Ophthalmology Disorders Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 OPHTHALMOLOGY DISORDERS DRUG BY REGIONS
4.1 Ophthalmology Disorders Drug Market Size by Regions (2017-2022)
4.2 Americas Ophthalmology Disorders Drug Market Size Growth (2017-2022)
4.3 APAC Ophthalmology Disorders Drug Market Size Growth (2017-2022)
4.4 Europe Ophthalmology Disorders Drug Market Size Growth (2017-2022)
4.5 Middle East & Africa Ophthalmology Disorders Drug Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Ophthalmology Disorders Drug Market Size by Country (2017-2022)
5.2 Americas Ophthalmology Disorders Drug Market Size by Type (2017-2022)
5.3 Americas Ophthalmology Disorders Drug Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ophthalmology Disorders Drug Market Size by Region (2017-2022)
6.2 APAC Ophthalmology Disorders Drug Market Size by Type (2017-2022)
6.3 APAC Ophthalmology Disorders Drug Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Ophthalmology Disorders Drug by Country (2017-2022)
7.2 Europe Ophthalmology Disorders Drug Market Size by Type (2017-2022)
7.3 Europe Ophthalmology Disorders Drug Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Ophthalmology Disorders Drug by Region (2017-2022)
8.2 Middle East & Africa Ophthalmology Disorders Drug Market Size by Type (2017-2022)
8.3 Middle East & Africa Ophthalmology Disorders Drug Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL OPHTHALMOLOGY DISORDERS DRUG MARKET FORECAST
10.1 Global Ophthalmology Disorders Drug Forecast by Regions (2023-2028)
10.1.1 Global Ophthalmology Disorders Drug Forecast by Regions (2023-2028)
10.1.2 Americas Ophthalmology Disorders Drug Forecast
10.1.3 APAC Ophthalmology Disorders Drug Forecast
10.1.4 Europe Ophthalmology Disorders Drug Forecast
10.1.5 Middle East & Africa Ophthalmology Disorders Drug Forecast
10.2 Americas Ophthalmology Disorders Drug Forecast by Country (2023-2028)
10.2.1 United States Ophthalmology Disorders Drug Market Forecast
10.2.2 Canada Ophthalmology Disorders Drug Market Forecast
10.2.3 Mexico Ophthalmology Disorders Drug Market Forecast
10.2.4 Brazil Ophthalmology Disorders Drug Market Forecast
10.3 APAC Ophthalmology Disorders Drug Forecast by Region (2023-2028)
10.3.1 China Ophthalmology Disorders Drug Market Forecast
10.3.2 Japan Ophthalmology Disorders Drug Market Forecast
10.3.3 Korea Ophthalmology Disorders Drug Market Forecast
10.3.4 Southeast Asia Ophthalmology Disorders Drug Market Forecast
10.3.5 India Ophthalmology Disorders Drug Market Forecast
10.3.6 Australia Ophthalmology Disorders Drug Market Forecast
10.4 Europe Ophthalmology Disorders Drug Forecast by Country (2023-2028)
10.4.1 Germany Ophthalmology Disorders Drug Market Forecast
10.4.2 France Ophthalmology Disorders Drug Market Forecast
10.4.3 UK Ophthalmology Disorders Drug Market Forecast
10.4.4 Italy Ophthalmology Disorders Drug Market Forecast
10.4.5 Russia Ophthalmology Disorders Drug Market Forecast
10.5 Middle East & Africa Ophthalmology Disorders Drug Forecast by Region (2023-2028)
10.5.1 Egypt Ophthalmology Disorders Drug Market Forecast
10.5.2 South Africa Ophthalmology Disorders Drug Market Forecast
10.5.3 Israel Ophthalmology Disorders Drug Market Forecast
10.5.4 Turkey Ophthalmology Disorders Drug Market Forecast
10.5.5 GCC Countries Ophthalmology Disorders Drug Market Forecast
10.6 Global Ophthalmology Disorders Drug Forecast by Type (2023-2028)
10.7 Global Ophthalmology Disorders Drug Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Ophthalmology Disorders Drug Product Offered
11.1.3 Sanofi Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 Bayer
11.2.1 Bayer Company Information
11.2.2 Bayer Ophthalmology Disorders Drug Product Offered
11.2.3 Bayer Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Bayer Main Business Overview
11.2.5 Bayer Latest Developments
11.3 Bausch + Lomb
11.3.1 Bausch + Lomb Company Information
11.3.2 Bausch + Lomb Ophthalmology Disorders Drug Product Offered
11.3.3 Bausch + Lomb Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Bausch + Lomb Main Business Overview
11.3.5 Bausch + Lomb Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Ophthalmology Disorders Drug Product Offered
11.4.3 Novartis Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Usher Syndrome
11.5.1 Usher Syndrome Company Information
11.5.2 Usher Syndrome Ophthalmology Disorders Drug Product Offered
11.5.3 Usher Syndrome Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Usher Syndrome Main Business Overview
11.5.5 Usher Syndrome Latest Developments
11.6 Takeda Pharmaceutical
11.6.1 Takeda Pharmaceutical Company Information
11.6.2 Takeda Pharmaceutical Ophthalmology Disorders Drug Product Offered
11.6.3 Takeda Pharmaceutical Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Takeda Pharmaceutical Main Business Overview
11.6.5 Takeda Pharmaceutical Latest Developments
11.7 Roche
11.7.1 Roche Company Information
11.7.2 Roche Ophthalmology Disorders Drug Product Offered
11.7.3 Roche Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Roche Main Business Overview
11.7.5 Roche Latest Developments
11.8 Pfizer
11.8.1 Pfizer Company Information
11.8.2 Pfizer Ophthalmology Disorders Drug Product Offered
11.8.3 Pfizer Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Pfizer Main Business Overview
11.8.5 Pfizer Latest Developments
11.9 Allergan
11.9.1 Allergan Company Information
11.9.2 Allergan Ophthalmology Disorders Drug Product Offered
11.9.3 Allergan Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Allergan Main Business Overview
11.9.5 Allergan Latest Developments
11.10 Gilead Sciences
11.10.1 Gilead Sciences Company Information
11.10.2 Gilead Sciences Ophthalmology Disorders Drug Product Offered
11.10.3 Gilead Sciences Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Gilead Sciences Main Business Overview
11.10.5 Gilead Sciences Latest Developments
11.11 Kubota Pharmaceutical
11.11.1 Kubota Pharmaceutical Company Information
11.11.2 Kubota Pharmaceutical Ophthalmology Disorders Drug Product Offered
11.11.3 Kubota Pharmaceutical Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Kubota Pharmaceutical Main Business Overview
11.11.5 Kubota Pharmaceutical Latest Developments
11.12 Alkeus Pharmaceuticals
11.12.1 Alkeus Pharmaceuticals Company Information
11.12.2 Alkeus Pharmaceuticals Ophthalmology Disorders Drug Product Offered
11.12.3 Alkeus Pharmaceuticals Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Alkeus Pharmaceuticals Main Business Overview
11.12.5 Alkeus Pharmaceuticals Latest Developments
11.13 Astellas Pharma
11.13.1 Astellas Pharma Company Information
11.13.2 Astellas Pharma Ophthalmology Disorders Drug Product Offered
11.13.3 Astellas Pharma Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Astellas Pharma Main Business Overview
11.13.5 Astellas Pharma Latest Developments
11.14 Ferrer Corporate
11.14.1 Ferrer Corporate Company Information
11.14.2 Ferrer Corporate Ophthalmology Disorders Drug Product Offered
11.14.3 Ferrer Corporate Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Ferrer Corporate Main Business Overview
11.14.5 Ferrer Corporate Latest Developments
11.15 Amgen Inc
11.15.1 Amgen Inc Company Information
11.15.2 Amgen Inc Ophthalmology Disorders Drug Product Offered
11.15.3 Amgen Inc Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Amgen Inc Main Business Overview
11.15.5 Amgen Inc Latest Developments
11.16 Editas Medicine Inc
11.16.1 Editas Medicine Inc Company Information
11.16.2 Editas Medicine Inc Ophthalmology Disorders Drug Product Offered
11.16.3 Editas Medicine Inc Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Editas Medicine Inc Main Business Overview
11.16.5 Editas Medicine Inc Latest Developments
11.17 ProQR Therapeutics NV
11.17.1 ProQR Therapeutics NV Company Information
11.17.2 ProQR Therapeutics NV Ophthalmology Disorders Drug Product Offered
11.17.3 ProQR Therapeutics NV Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 ProQR Therapeutics NV Main Business Overview
11.17.5 ProQR Therapeutics NV Latest Developments
11.18 ReNeuron
11.18.1 ReNeuron Company Information
11.18.2 ReNeuron Ophthalmology Disorders Drug Product Offered
11.18.3 ReNeuron Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 ReNeuron Main Business Overview
11.18.5 ReNeuron Latest Developments
11.19 Amarantus BioScience
11.19.1 Amarantus BioScience Company Information
11.19.2 Amarantus BioScience Ophthalmology Disorders Drug Product Offered
11.19.3 Amarantus BioScience Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 Amarantus BioScience Main Business Overview
11.19.5 Amarantus BioScience Latest Developments
11.20 Ocugen
11.20.1 Ocugen Company Information
11.20.2 Ocugen Ophthalmology Disorders Drug Product Offered
11.20.3 Ocugen Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 Ocugen Main Business Overview
11.20.5 Ocugen Latest Developments
11.21 ReGenX Biosciences
11.21.1 ReGenX Biosciences Company Information
11.21.2 ReGenX Biosciences Ophthalmology Disorders Drug Product Offered
11.21.3 ReGenX Biosciences Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.21.4 ReGenX Biosciences Main Business Overview
11.21.5 ReGenX Biosciences Latest Developments
11.22 Sucampo Pharmaceuticals
11.22.1 Sucampo Pharmaceuticals Company Information
11.22.2 Sucampo Pharmaceuticals Ophthalmology Disorders Drug Product Offered
11.22.3 Sucampo Pharmaceuticals Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.22.4 Sucampo Pharmaceuticals Main Business Overview
11.22.5 Sucampo Pharmaceuticals Latest Developments
11.23 Orphagen Pharmaceuticals
11.23.1 Orphagen Pharmaceuticals Company Information
11.23.2 Orphagen Pharmaceuticals Ophthalmology Disorders Drug Product Offered
11.23.3 Orphagen Pharmaceuticals Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.23.4 Orphagen Pharmaceuticals Main Business Overview
11.23.5 Orphagen Pharmaceuticals Latest Developments
11.24 Okuvision
11.24.1 Okuvision Company Information
11.24.2 Okuvision Ophthalmology Disorders Drug Product Offered
11.24.3 Okuvision Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.24.4 Okuvision Main Business Overview
11.24.5 Okuvision Latest Developments
11.25 Second Sight Medical
11.25.1 Second Sight Medical Company Information
11.25.2 Second Sight Medical Ophthalmology Disorders Drug Product Offered
11.25.3 Second Sight Medical Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.25.4 Second Sight Medical Main Business Overview
11.25.5 Second Sight Medical Latest Developments
11.26 Acucela
11.26.1 Acucela Company Information
11.26.2 Acucela Ophthalmology Disorders Drug Product Offered
11.26.3 Acucela Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.26.4 Acucela Main Business Overview
11.26.5 Acucela Latest Developments
11.27 Stealth BioTherapeutics
11.27.1 Stealth BioTherapeutics Company Information
11.27.2 Stealth BioTherapeutics Ophthalmology Disorders Drug Product Offered
11.27.3 Stealth BioTherapeutics Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.27.4 Stealth BioTherapeutics Main Business Overview
11.27.5 Stealth BioTherapeutics Latest Developments
11.28 Sun Pharma Advanced Research Company
11.28.1 Sun Pharma Advanced Research Company Company Information
11.28.2 Sun Pharma Advanced Research Company Ophthalmology Disorders Drug Product Offered
11.28.3 Sun Pharma Advanced Research Company Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.28.4 Sun Pharma Advanced Research Company Main Business Overview
11.28.5 Sun Pharma Advanced Research Company Latest Developments
11.29 AmpliPhi Biosciences
11.29.1 AmpliPhi Biosciences Company Information
11.29.2 AmpliPhi Biosciences Ophthalmology Disorders Drug Product Offered
11.29.3 AmpliPhi Biosciences Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.29.4 AmpliPhi Biosciences Main Business Overview
11.29.5 AmpliPhi Biosciences Latest Developments
11.30 Applied Genetic Technologies
11.30.1 Applied Genetic Technologies Company Information
11.30.2 Applied Genetic Technologies Ophthalmology Disorders Drug Product Offered
11.30.3 Applied Genetic Technologies Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.30.4 Applied Genetic Technologies Main Business Overview
11.30.5 Applied Genetic Technologies Latest Developments
11.31 Asklepios BioPharmaceutical
11.31.1 Asklepios BioPharmaceutical Company Information
11.31.2 Asklepios BioPharmaceutical Ophthalmology Disorders Drug Product Offered
11.31.3 Asklepios BioPharmaceutical Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.31.4 Asklepios BioPharmaceutical Main Business Overview
11.31.5 Asklepios BioPharmaceutical Latest Developments
11.32 Biovista
11.32.1 Biovista Company Information
11.32.2 Biovista Ophthalmology Disorders Drug Product Offered
11.32.3 Biovista Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.32.4 Biovista Main Business Overview
11.32.5 Biovista Latest Developments
11.33 Spark Therapeutics
11.33.1 Spark Therapeutics Company Information
11.33.2 Spark Therapeutics Ophthalmology Disorders Drug Product Offered
11.33.3 Spark Therapeutics Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.33.4 Spark Therapeutics Main Business Overview
11.33.5 Spark Therapeutics Latest Developments
11.34 Caladrius Biosciences
11.34.1 Caladrius Biosciences Company Information
11.34.2 Caladrius Biosciences Ophthalmology Disorders Drug Product Offered
11.34.3 Caladrius Biosciences Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.34.4 Caladrius Biosciences Main Business Overview
11.34.5 Caladrius Biosciences Latest Developments
11.35 Dompe Farmaceutici
11.35.1 Dompe Farmaceutici Company Information
11.35.2 Dompe Farmaceutici Ophthalmology Disorders Drug Product Offered
11.35.3 Dompe Farmaceutici Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.35.4 Dompe Farmaceutici Main Business Overview
11.35.5 Dompe Farmaceutici Latest Developments
11.36 Dormant Projects
11.36.1 Dormant Projects Company Information
11.36.2 Dormant Projects Ophthalmology Disorders Drug Product Offered
11.36.3 Dormant Projects Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.36.4 Dormant Projects Main Business Overview
11.36.5 Dormant Projects Latest Developments
11.37 Grupo Ferrer Internacional
11.37.1 Grupo Ferrer Internacional Company Information
11.37.2 Grupo Ferrer Internacional Ophthalmology Disorders Drug Product Offered
11.37.3 Grupo Ferrer Internacional Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.37.4 Grupo Ferrer Internacional Main Business Overview
11.37.5 Grupo Ferrer Internacional Latest Developments
11.38 ID Pharma
11.38.1 ID Pharma Company Information
11.38.2 ID Pharma Ophthalmology Disorders Drug Product Offered
11.38.3 ID Pharma Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.38.4 ID Pharma Main Business Overview
11.38.5 ID Pharma Latest Developments
11.39 InFlectis BioScience
11.39.1 InFlectis BioScience Company Information
11.39.2 InFlectis BioScience Ophthalmology Disorders Drug Product Offered
11.39.3 InFlectis BioScience Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.39.4 InFlectis BioScience Main Business Overview
11.39.5 InFlectis BioScience Latest Developments
11.40 Ionis Pharmaceuticals
11.40.1 Ionis Pharmaceuticals Company Information
11.40.2 Ionis Pharmaceuticals Ophthalmology Disorders Drug Product Offered
11.40.3 Ionis Pharmaceuticals Ophthalmology Disorders Drug Revenue, Gross Margin and Market Share (2020-2022)
11.40.4 Ionis Pharmaceuticals Main Business Overview
11.40.5 Ionis Pharmaceuticals Latest Developments
11.41 Ixchel Pharma
11.42 Khondrion
11.43 Mimetogen Pharmaceuticals
11.44 Mitotech
11.45 M's Science
11.46 Nanovector
11.47 SanBio
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Ophthalmology Disorders Drug Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Oral
Table 3. Major Players of Injection
Table 4. Major Players of External Use
Table 5. Ophthalmology Disorders Drug Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Ophthalmology Disorders Drug Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Ophthalmology Disorders Drug Market Size Market Share by Type (2017-2022)
Table 8. Ophthalmology Disorders Drug Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Ophthalmology Disorders Drug Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Ophthalmology Disorders Drug Market Size Market Share by Application (2017-2022)
Table 11. Global Ophthalmology Disorders Drug Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Ophthalmology Disorders Drug Revenue Market Share by Player (2020-2022)
Table 13. Ophthalmology Disorders Drug Key Players Head office and Products Offered
Table 14. Ophthalmology Disorders Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Ophthalmology Disorders Drug Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Ophthalmology Disorders Drug Market Size Market Share by Regions (2017-2022)
Table 19. Americas Ophthalmology Disorders Drug Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Ophthalmology Disorders Drug Market Size Market Share by Country (2017-2022)
Table 21. Americas Ophthalmology Disorders Drug Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Ophthalmology Disorders Drug Market Size Market Share by Type (2017-2022)
Table 23. Americas Ophthalmology Disorders Drug Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Ophthalmology Disorders Drug Market Size Market Share by Application (2017-2022)
Table 25. APAC Ophthalmology Disorders Drug Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Ophthalmology Disorders Drug Market Size Market Share by Region (2017-2022)
Table 27. APAC Ophthalmology Disorders Drug Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Ophthalmology Disorders Drug Market Size Market Share by Type (2017-2022)
Table 29. APAC Ophthalmology Disorders Drug Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Ophthalmology Disorders Drug Market Size Market Share by Application (2017-2022)
Table 31. Europe Ophthalmology Disorders Drug Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Ophthalmology Disorders Drug Market Size Market Share by Country (2017-2022)
Table 33. Europe Ophthalmology Disorders Drug Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Ophthalmology Disorders Drug Market Size Market Share by Type (2017-2022)
Table 35. Europe Ophthalmology Disorders Drug Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Ophthalmology Disorders Drug Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Ophthalmology Disorders Drug Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Ophthalmology Disorders Drug Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Ophthalmology Disorders Drug Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Ophthalmology Disorders Drug Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Ophthalmology Disorders Drug Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Ophthalmology Disorders Drug Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Ophthalmology Disorders Drug
Table 44. Key Market Challenges & Risks of Ophthalmology Disorders Drug
Table 45. Key Industry Trends of Ophthalmology Disorders Drug
Table 46. Global Ophthalmology Disorders Drug Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Ophthalmology Disorders Drug Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Ophthalmology Disorders Drug Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Ophthalmology Disorders Drug Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Ophthalmology Disorders Drug Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Ophthalmology Disorders Drug Market Size Market Share Forecast by Application (2023-2028)
Table 52. Sanofi Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 53. Sanofi Ophthalmology Disorders Drug Product Offered
Table 54. Sanofi Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Sanofi Main Business
Table 56. Sanofi Latest Developments
Table 57. Bayer Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 58. Bayer Ophthalmology Disorders Drug Product Offered
Table 59. Bayer Main Business
Table 60. Bayer Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Bayer Latest Developments
Table 62. Bausch + Lomb Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 63. Bausch + Lomb Ophthalmology Disorders Drug Product Offered
Table 64. Bausch + Lomb Main Business
Table 65. Bausch + Lomb Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Bausch + Lomb Latest Developments
Table 67. Novartis Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 68. Novartis Ophthalmology Disorders Drug Product Offered
Table 69. Novartis Main Business
Table 70. Novartis Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Novartis Latest Developments
Table 72. Usher Syndrome Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 73. Usher Syndrome Ophthalmology Disorders Drug Product Offered
Table 74. Usher Syndrome Main Business
Table 75. Usher Syndrome Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Usher Syndrome Latest Developments
Table 77. Takeda Pharmaceutical Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 78. Takeda Pharmaceutical Ophthalmology Disorders Drug Product Offered
Table 79. Takeda Pharmaceutical Main Business
Table 80. Takeda Pharmaceutical Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Takeda Pharmaceutical Latest Developments
Table 82. Roche Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 83. Roche Ophthalmology Disorders Drug Product Offered
Table 84. Roche Main Business
Table 85. Roche Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Roche Latest Developments
Table 87. Pfizer Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 88. Pfizer Ophthalmology Disorders Drug Product Offered
Table 89. Pfizer Main Business
Table 90. Pfizer Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Pfizer Latest Developments
Table 92. Allergan Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 93. Allergan Ophthalmology Disorders Drug Product Offered
Table 94. Allergan Main Business
Table 95. Allergan Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. Allergan Latest Developments
Table 97. Gilead Sciences Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 98. Gilead Sciences Ophthalmology Disorders Drug Product Offered
Table 99. Gilead Sciences Main Business
Table 100. Gilead Sciences Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. Gilead Sciences Latest Developments
Table 102. Kubota Pharmaceutical Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 103. Kubota Pharmaceutical Ophthalmology Disorders Drug Product Offered
Table 104. Kubota Pharmaceutical Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Kubota Pharmaceutical Main Business
Table 106. Kubota Pharmaceutical Latest Developments
Table 107. Alkeus Pharmaceuticals Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 108. Alkeus Pharmaceuticals Ophthalmology Disorders Drug Product Offered
Table 109. Alkeus Pharmaceuticals Main Business
Table 110. Alkeus Pharmaceuticals Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 111. Alkeus Pharmaceuticals Latest Developments
Table 112. Astellas Pharma Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 113. Astellas Pharma Ophthalmology Disorders Drug Product Offered
Table 114. Astellas Pharma Main Business
Table 115. Astellas Pharma Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 116. Astellas Pharma Latest Developments
Table 117. Ferrer Corporate Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 118. Ferrer Corporate Ophthalmology Disorders Drug Product Offered
Table 119. Ferrer Corporate Main Business
Table 120. Ferrer Corporate Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 121. Ferrer Corporate Latest Developments
Table 122. Amgen Inc Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 123. Amgen Inc Ophthalmology Disorders Drug Product Offered
Table 124. Amgen Inc Main Business
Table 125. Amgen Inc Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 126. Amgen Inc Latest Developments
Table 127. Editas Medicine Inc Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 128. Editas Medicine Inc Ophthalmology Disorders Drug Product Offered
Table 129. Editas Medicine Inc Main Business
Table 130. Editas Medicine Inc Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 131. Editas Medicine Inc Latest Developments
Table 132. ProQR Therapeutics NV Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 133. ProQR Therapeutics NV Ophthalmology Disorders Drug Product Offered
Table 134. ProQR Therapeutics NV Main Business
Table 135. ProQR Therapeutics NV Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 136. ProQR Therapeutics NV Latest Developments
Table 137. ReNeuron Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 138. ReNeuron Ophthalmology Disorders Drug Product Offered
Table 139. ReNeuron Main Business
Table 140. ReNeuron Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 141. ReNeuron Latest Developments
Table 142. Amarantus BioScience Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 143. Amarantus BioScience Ophthalmology Disorders Drug Product Offered
Table 144. Amarantus BioScience Main Business
Table 145. Amarantus BioScience Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 146. Amarantus BioScience Latest Developments
Table 147. Ocugen Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 148. Ocugen Ophthalmology Disorders Drug Product Offered
Table 149. Ocugen Main Business
Table 150. Ocugen Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 151. Ocugen Latest Developments
Table 152. ReGenX Biosciences Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 153. ReGenX Biosciences Ophthalmology Disorders Drug Product Offered
Table 154. ReGenX Biosciences Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 155. ReGenX Biosciences Main Business
Table 156. ReGenX Biosciences Latest Developments
Table 157. Sucampo Pharmaceuticals Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 158. Sucampo Pharmaceuticals Ophthalmology Disorders Drug Product Offered
Table 159. Sucampo Pharmaceuticals Main Business
Table 160. Sucampo Pharmaceuticals Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 161. Sucampo Pharmaceuticals Latest Developments
Table 162. Orphagen Pharmaceuticals Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 163. Orphagen Pharmaceuticals Ophthalmology Disorders Drug Product Offered
Table 164. Orphagen Pharmaceuticals Main Business
Table 165. Orphagen Pharmaceuticals Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 166. Orphagen Pharmaceuticals Latest Developments
Table 167. Okuvision Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 168. Okuvision Ophthalmology Disorders Drug Product Offered
Table 169. Okuvision Main Business
Table 170. Okuvision Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 171. Okuvision Latest Developments
Table 172. Second Sight Medical Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 173. Second Sight Medical Ophthalmology Disorders Drug Product Offered
Table 174. Second Sight Medical Main Business
Table 175. Second Sight Medical Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 176. Second Sight Medical Latest Developments
Table 177. Acucela Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 178. Acucela Ophthalmology Disorders Drug Product Offered
Table 179. Acucela Main Business
Table 180. Acucela Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 181. Acucela Latest Developments
Table 182. Stealth BioTherapeutics Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 183. Stealth BioTherapeutics Ophthalmology Disorders Drug Product Offered
Table 184. Stealth BioTherapeutics Main Business
Table 185. Stealth BioTherapeutics Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 186. Stealth BioTherapeutics Latest Developments
Table 187. Sun Pharma Advanced Research Company Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 188. Sun Pharma Advanced Research Company Ophthalmology Disorders Drug Product Offered
Table 189. Sun Pharma Advanced Research Company Main Business
Table 190. Sun Pharma Advanced Research Company Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 191. Sun Pharma Advanced Research Company Latest Developments
Table 192. AmpliPhi Biosciences Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 193. AmpliPhi Biosciences Ophthalmology Disorders Drug Product Offered
Table 194. AmpliPhi Biosciences Main Business
Table 195. AmpliPhi Biosciences Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 196. AmpliPhi Biosciences Latest Developments
Table 197. Applied Genetic Technologies Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 198. Applied Genetic Technologies Ophthalmology Disorders Drug Product Offered
Table 199. Applied Genetic Technologies Main Business
Table 200. Applied Genetic Technologies Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 201. Applied Genetic Technologies Latest Developments
Table 202. Asklepios BioPharmaceutical Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 203. Asklepios BioPharmaceutical Ophthalmology Disorders Drug Product Offered
Table 204. Asklepios BioPharmaceutical Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 205. Asklepios BioPharmaceutical Main Business
Table 206. Asklepios BioPharmaceutical Latest Developments
Table 207. Biovista Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 208. Biovista Ophthalmology Disorders Drug Product Offered
Table 209. Biovista Main Business
Table 210. Biovista Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 211. Biovista Latest Developments
Table 212. Spark Therapeutics Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 213. Spark Therapeutics Ophthalmology Disorders Drug Product Offered
Table 214. Spark Therapeutics Main Business
Table 215. Spark Therapeutics Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 216. Spark Therapeutics Latest Developments
Table 217. Caladrius Biosciences Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 218. Caladrius Biosciences Ophthalmology Disorders Drug Product Offered
Table 219. Caladrius Biosciences Main Business
Table 220. Caladrius Biosciences Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 221. Caladrius Biosciences Latest Developments
Table 222. Dompe Farmaceutici Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 223. Dompe Farmaceutici Ophthalmology Disorders Drug Product Offered
Table 224. Dompe Farmaceutici Main Business
Table 225. Dompe Farmaceutici Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 226. Dompe Farmaceutici Latest Developments
Table 227. Dormant Projects Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 228. Dormant Projects Ophthalmology Disorders Drug Product Offered
Table 229. Dormant Projects Main Business
Table 230. Dormant Projects Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 231. Dormant Projects Latest Developments
Table 232. Grupo Ferrer Internacional Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 233. Grupo Ferrer Internacional Ophthalmology Disorders Drug Product Offered
Table 234. Grupo Ferrer Internacional Main Business
Table 235. Grupo Ferrer Internacional Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 236. Grupo Ferrer Internacional Latest Developments
Table 237. ID Pharma Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 238. ID Pharma Ophthalmology Disorders Drug Product Offered
Table 239. ID Pharma Main Business
Table 240. ID Pharma Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 241. ID Pharma Latest Developments
Table 242. InFlectis BioScience Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 243. Ionis Pharmaceuticals Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 244. Ixchel Pharma Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 245. Khondrion Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 246. Mimetogen Pharmaceuticals Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 247. Mitotech Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 248. M's Science Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 249. Nanovector Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 250. SanBio Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 1. Ophthalmology Disorders Drug Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Oral
Table 3. Major Players of Injection
Table 4. Major Players of External Use
Table 5. Ophthalmology Disorders Drug Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Ophthalmology Disorders Drug Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Ophthalmology Disorders Drug Market Size Market Share by Type (2017-2022)
Table 8. Ophthalmology Disorders Drug Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Ophthalmology Disorders Drug Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Ophthalmology Disorders Drug Market Size Market Share by Application (2017-2022)
Table 11. Global Ophthalmology Disorders Drug Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Ophthalmology Disorders Drug Revenue Market Share by Player (2020-2022)
Table 13. Ophthalmology Disorders Drug Key Players Head office and Products Offered
Table 14. Ophthalmology Disorders Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Ophthalmology Disorders Drug Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Ophthalmology Disorders Drug Market Size Market Share by Regions (2017-2022)
Table 19. Americas Ophthalmology Disorders Drug Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Ophthalmology Disorders Drug Market Size Market Share by Country (2017-2022)
Table 21. Americas Ophthalmology Disorders Drug Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Ophthalmology Disorders Drug Market Size Market Share by Type (2017-2022)
Table 23. Americas Ophthalmology Disorders Drug Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Ophthalmology Disorders Drug Market Size Market Share by Application (2017-2022)
Table 25. APAC Ophthalmology Disorders Drug Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Ophthalmology Disorders Drug Market Size Market Share by Region (2017-2022)
Table 27. APAC Ophthalmology Disorders Drug Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Ophthalmology Disorders Drug Market Size Market Share by Type (2017-2022)
Table 29. APAC Ophthalmology Disorders Drug Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Ophthalmology Disorders Drug Market Size Market Share by Application (2017-2022)
Table 31. Europe Ophthalmology Disorders Drug Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Ophthalmology Disorders Drug Market Size Market Share by Country (2017-2022)
Table 33. Europe Ophthalmology Disorders Drug Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Ophthalmology Disorders Drug Market Size Market Share by Type (2017-2022)
Table 35. Europe Ophthalmology Disorders Drug Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Ophthalmology Disorders Drug Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Ophthalmology Disorders Drug Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Ophthalmology Disorders Drug Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Ophthalmology Disorders Drug Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Ophthalmology Disorders Drug Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Ophthalmology Disorders Drug Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Ophthalmology Disorders Drug Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Ophthalmology Disorders Drug
Table 44. Key Market Challenges & Risks of Ophthalmology Disorders Drug
Table 45. Key Industry Trends of Ophthalmology Disorders Drug
Table 46. Global Ophthalmology Disorders Drug Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Ophthalmology Disorders Drug Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Ophthalmology Disorders Drug Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Ophthalmology Disorders Drug Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Ophthalmology Disorders Drug Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Ophthalmology Disorders Drug Market Size Market Share Forecast by Application (2023-2028)
Table 52. Sanofi Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 53. Sanofi Ophthalmology Disorders Drug Product Offered
Table 54. Sanofi Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Sanofi Main Business
Table 56. Sanofi Latest Developments
Table 57. Bayer Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 58. Bayer Ophthalmology Disorders Drug Product Offered
Table 59. Bayer Main Business
Table 60. Bayer Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Bayer Latest Developments
Table 62. Bausch + Lomb Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 63. Bausch + Lomb Ophthalmology Disorders Drug Product Offered
Table 64. Bausch + Lomb Main Business
Table 65. Bausch + Lomb Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Bausch + Lomb Latest Developments
Table 67. Novartis Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 68. Novartis Ophthalmology Disorders Drug Product Offered
Table 69. Novartis Main Business
Table 70. Novartis Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Novartis Latest Developments
Table 72. Usher Syndrome Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 73. Usher Syndrome Ophthalmology Disorders Drug Product Offered
Table 74. Usher Syndrome Main Business
Table 75. Usher Syndrome Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Usher Syndrome Latest Developments
Table 77. Takeda Pharmaceutical Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 78. Takeda Pharmaceutical Ophthalmology Disorders Drug Product Offered
Table 79. Takeda Pharmaceutical Main Business
Table 80. Takeda Pharmaceutical Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Takeda Pharmaceutical Latest Developments
Table 82. Roche Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 83. Roche Ophthalmology Disorders Drug Product Offered
Table 84. Roche Main Business
Table 85. Roche Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Roche Latest Developments
Table 87. Pfizer Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 88. Pfizer Ophthalmology Disorders Drug Product Offered
Table 89. Pfizer Main Business
Table 90. Pfizer Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Pfizer Latest Developments
Table 92. Allergan Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 93. Allergan Ophthalmology Disorders Drug Product Offered
Table 94. Allergan Main Business
Table 95. Allergan Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. Allergan Latest Developments
Table 97. Gilead Sciences Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 98. Gilead Sciences Ophthalmology Disorders Drug Product Offered
Table 99. Gilead Sciences Main Business
Table 100. Gilead Sciences Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. Gilead Sciences Latest Developments
Table 102. Kubota Pharmaceutical Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 103. Kubota Pharmaceutical Ophthalmology Disorders Drug Product Offered
Table 104. Kubota Pharmaceutical Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Kubota Pharmaceutical Main Business
Table 106. Kubota Pharmaceutical Latest Developments
Table 107. Alkeus Pharmaceuticals Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 108. Alkeus Pharmaceuticals Ophthalmology Disorders Drug Product Offered
Table 109. Alkeus Pharmaceuticals Main Business
Table 110. Alkeus Pharmaceuticals Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 111. Alkeus Pharmaceuticals Latest Developments
Table 112. Astellas Pharma Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 113. Astellas Pharma Ophthalmology Disorders Drug Product Offered
Table 114. Astellas Pharma Main Business
Table 115. Astellas Pharma Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 116. Astellas Pharma Latest Developments
Table 117. Ferrer Corporate Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 118. Ferrer Corporate Ophthalmology Disorders Drug Product Offered
Table 119. Ferrer Corporate Main Business
Table 120. Ferrer Corporate Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 121. Ferrer Corporate Latest Developments
Table 122. Amgen Inc Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 123. Amgen Inc Ophthalmology Disorders Drug Product Offered
Table 124. Amgen Inc Main Business
Table 125. Amgen Inc Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 126. Amgen Inc Latest Developments
Table 127. Editas Medicine Inc Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 128. Editas Medicine Inc Ophthalmology Disorders Drug Product Offered
Table 129. Editas Medicine Inc Main Business
Table 130. Editas Medicine Inc Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 131. Editas Medicine Inc Latest Developments
Table 132. ProQR Therapeutics NV Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 133. ProQR Therapeutics NV Ophthalmology Disorders Drug Product Offered
Table 134. ProQR Therapeutics NV Main Business
Table 135. ProQR Therapeutics NV Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 136. ProQR Therapeutics NV Latest Developments
Table 137. ReNeuron Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 138. ReNeuron Ophthalmology Disorders Drug Product Offered
Table 139. ReNeuron Main Business
Table 140. ReNeuron Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 141. ReNeuron Latest Developments
Table 142. Amarantus BioScience Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 143. Amarantus BioScience Ophthalmology Disorders Drug Product Offered
Table 144. Amarantus BioScience Main Business
Table 145. Amarantus BioScience Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 146. Amarantus BioScience Latest Developments
Table 147. Ocugen Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 148. Ocugen Ophthalmology Disorders Drug Product Offered
Table 149. Ocugen Main Business
Table 150. Ocugen Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 151. Ocugen Latest Developments
Table 152. ReGenX Biosciences Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 153. ReGenX Biosciences Ophthalmology Disorders Drug Product Offered
Table 154. ReGenX Biosciences Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 155. ReGenX Biosciences Main Business
Table 156. ReGenX Biosciences Latest Developments
Table 157. Sucampo Pharmaceuticals Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 158. Sucampo Pharmaceuticals Ophthalmology Disorders Drug Product Offered
Table 159. Sucampo Pharmaceuticals Main Business
Table 160. Sucampo Pharmaceuticals Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 161. Sucampo Pharmaceuticals Latest Developments
Table 162. Orphagen Pharmaceuticals Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 163. Orphagen Pharmaceuticals Ophthalmology Disorders Drug Product Offered
Table 164. Orphagen Pharmaceuticals Main Business
Table 165. Orphagen Pharmaceuticals Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 166. Orphagen Pharmaceuticals Latest Developments
Table 167. Okuvision Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 168. Okuvision Ophthalmology Disorders Drug Product Offered
Table 169. Okuvision Main Business
Table 170. Okuvision Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 171. Okuvision Latest Developments
Table 172. Second Sight Medical Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 173. Second Sight Medical Ophthalmology Disorders Drug Product Offered
Table 174. Second Sight Medical Main Business
Table 175. Second Sight Medical Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 176. Second Sight Medical Latest Developments
Table 177. Acucela Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 178. Acucela Ophthalmology Disorders Drug Product Offered
Table 179. Acucela Main Business
Table 180. Acucela Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 181. Acucela Latest Developments
Table 182. Stealth BioTherapeutics Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 183. Stealth BioTherapeutics Ophthalmology Disorders Drug Product Offered
Table 184. Stealth BioTherapeutics Main Business
Table 185. Stealth BioTherapeutics Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 186. Stealth BioTherapeutics Latest Developments
Table 187. Sun Pharma Advanced Research Company Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 188. Sun Pharma Advanced Research Company Ophthalmology Disorders Drug Product Offered
Table 189. Sun Pharma Advanced Research Company Main Business
Table 190. Sun Pharma Advanced Research Company Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 191. Sun Pharma Advanced Research Company Latest Developments
Table 192. AmpliPhi Biosciences Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 193. AmpliPhi Biosciences Ophthalmology Disorders Drug Product Offered
Table 194. AmpliPhi Biosciences Main Business
Table 195. AmpliPhi Biosciences Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 196. AmpliPhi Biosciences Latest Developments
Table 197. Applied Genetic Technologies Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 198. Applied Genetic Technologies Ophthalmology Disorders Drug Product Offered
Table 199. Applied Genetic Technologies Main Business
Table 200. Applied Genetic Technologies Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 201. Applied Genetic Technologies Latest Developments
Table 202. Asklepios BioPharmaceutical Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 203. Asklepios BioPharmaceutical Ophthalmology Disorders Drug Product Offered
Table 204. Asklepios BioPharmaceutical Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 205. Asklepios BioPharmaceutical Main Business
Table 206. Asklepios BioPharmaceutical Latest Developments
Table 207. Biovista Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 208. Biovista Ophthalmology Disorders Drug Product Offered
Table 209. Biovista Main Business
Table 210. Biovista Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 211. Biovista Latest Developments
Table 212. Spark Therapeutics Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 213. Spark Therapeutics Ophthalmology Disorders Drug Product Offered
Table 214. Spark Therapeutics Main Business
Table 215. Spark Therapeutics Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 216. Spark Therapeutics Latest Developments
Table 217. Caladrius Biosciences Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 218. Caladrius Biosciences Ophthalmology Disorders Drug Product Offered
Table 219. Caladrius Biosciences Main Business
Table 220. Caladrius Biosciences Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 221. Caladrius Biosciences Latest Developments
Table 222. Dompe Farmaceutici Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 223. Dompe Farmaceutici Ophthalmology Disorders Drug Product Offered
Table 224. Dompe Farmaceutici Main Business
Table 225. Dompe Farmaceutici Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 226. Dompe Farmaceutici Latest Developments
Table 227. Dormant Projects Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 228. Dormant Projects Ophthalmology Disorders Drug Product Offered
Table 229. Dormant Projects Main Business
Table 230. Dormant Projects Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 231. Dormant Projects Latest Developments
Table 232. Grupo Ferrer Internacional Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 233. Grupo Ferrer Internacional Ophthalmology Disorders Drug Product Offered
Table 234. Grupo Ferrer Internacional Main Business
Table 235. Grupo Ferrer Internacional Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 236. Grupo Ferrer Internacional Latest Developments
Table 237. ID Pharma Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 238. ID Pharma Ophthalmology Disorders Drug Product Offered
Table 239. ID Pharma Main Business
Table 240. ID Pharma Ophthalmology Disorders Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 241. ID Pharma Latest Developments
Table 242. InFlectis BioScience Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 243. Ionis Pharmaceuticals Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 244. Ixchel Pharma Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 245. Khondrion Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 246. Mimetogen Pharmaceuticals Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 247. Mitotech Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 248. M's Science Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 249. Nanovector Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
Table 250. SanBio Details, Company Type, Ophthalmology Disorders Drug Area Served and Its Competitors
LIST OF FIGURES
Figure 1. Ophthalmology Disorders Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Ophthalmology Disorders Drug Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Ophthalmology Disorders Drug Market Size Market Share by Type in 2021
Figure 7. Ophthalmology Disorders Drug in Juvenile Macular Degeneration (Stargardt Disease)
Figure 8. Global Ophthalmology Disorders Drug Market: Juvenile Macular Degeneration (Stargardt Disease) (2017-2022) & ($ Millions)
Figure 9. Ophthalmology Disorders Drug in Leber Congenital Amaurosis (LCA)
Figure 10. Global Ophthalmology Disorders Drug Market: Leber Congenital Amaurosis (LCA) (2017-2022) & ($ Millions)
Figure 11. Ophthalmology Disorders Drug in Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)
Figure 12. Global Ophthalmology Disorders Drug Market: Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) (2017-2022) & ($ Millions)
Figure 13. Ophthalmology Disorders Drug in Usher Syndrome
Figure 14. Global Ophthalmology Disorders Drug Market: Usher Syndrome (2017-2022) & ($ Millions)
Figure 15. Ophthalmology Disorders Drug in Retinitis Pigmentosa (Retinitis)
Figure 16. Global Ophthalmology Disorders Drug Market: Retinitis Pigmentosa (Retinitis) (2017-2022) & ($ Millions)
Figure 17. Global Ophthalmology Disorders Drug Market Size Market Share by Application in 2021
Figure 18. Global Ophthalmology Disorders Drug Revenue Market Share by Player in 2021
Figure 19. Global Ophthalmology Disorders Drug Market Size Market Share by Regions (2017-2022)
Figure 20. Americas Ophthalmology Disorders Drug Market Size 2017-2022 ($ Millions)
Figure 21. APAC Ophthalmology Disorders Drug Market Size 2017-2022 ($ Millions)
Figure 22. Europe Ophthalmology Disorders Drug Market Size 2017-2022 ($ Millions)
Figure 23. Middle East & Africa Ophthalmology Disorders Drug Market Size 2017-2022 ($ Millions)
Figure 24. Americas Ophthalmology Disorders Drug Value Market Share by Country in 2021
Figure 25. Americas Ophthalmology Disorders Drug Consumption Market Share by Type in 2021
Figure 26. Americas Ophthalmology Disorders Drug Market Size Market Share by Application in 2021
Figure 27. United States Ophthalmology Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 28. Canada Ophthalmology Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 29. Mexico Ophthalmology Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 30. Brazil Ophthalmology Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 31. APAC Ophthalmology Disorders Drug Market Size Market Share by Region in 2021
Figure 32. APAC Ophthalmology Disorders Drug Market Size Market Share by Application in 2021
Figure 33. China Ophthalmology Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 34. Japan Ophthalmology Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 35. Korea Ophthalmology Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 36. Southeast Asia Ophthalmology Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 37. India Ophthalmology Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 38. Australia Ophthalmology Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 39. Europe Ophthalmology Disorders Drug Market Size Market Share by Country in 2021
Figure 40. Europe Ophthalmology Disorders Drug Market Size Market Share by Type in 2021
Figure 41. Europe Ophthalmology Disorders Drug Market Size Market Share by Application in 2021
Figure 42. Germany Ophthalmology Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 43. France Ophthalmology Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 44. UK Ophthalmology Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 45. Italy Ophthalmology Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 46. Russia Ophthalmology Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 47. Middle East & Africa Ophthalmology Disorders Drug Market Size Market Share by Region in 2021
Figure 48. Middle East & Africa Ophthalmology Disorders Drug Market Size Market Share by Type in 2021
Figure 49. Middle East & Africa Ophthalmology Disorders Drug Market Size Market Share by Application in 2021
Figure 50. Egypt Ophthalmology Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 51. South Africa Ophthalmology Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 52. Israel Ophthalmology Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 53. Turkey Ophthalmology Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 54. GCC Country Ophthalmology Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 55. Americas Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 56. APAC Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 57. Europe Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 58. Middle East & Africa Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 59. United States Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 60. Canada Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 61. Mexico Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 62. Brazil Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 63. China Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 64. Japan Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 65. Korea Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 66. Southeast Asia Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 67. India Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 68. Australia Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 69. Germany Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 70. France Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 71. UK Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 72. Italy Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 73. Russia Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 74. Spain Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 75. Egypt Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 76. South Africa Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 77. Israel Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 78. Turkey Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 79. GCC Countries Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 1. Ophthalmology Disorders Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Ophthalmology Disorders Drug Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Ophthalmology Disorders Drug Market Size Market Share by Type in 2021
Figure 7. Ophthalmology Disorders Drug in Juvenile Macular Degeneration (Stargardt Disease)
Figure 8. Global Ophthalmology Disorders Drug Market: Juvenile Macular Degeneration (Stargardt Disease) (2017-2022) & ($ Millions)
Figure 9. Ophthalmology Disorders Drug in Leber Congenital Amaurosis (LCA)
Figure 10. Global Ophthalmology Disorders Drug Market: Leber Congenital Amaurosis (LCA) (2017-2022) & ($ Millions)
Figure 11. Ophthalmology Disorders Drug in Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)
Figure 12. Global Ophthalmology Disorders Drug Market: Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) (2017-2022) & ($ Millions)
Figure 13. Ophthalmology Disorders Drug in Usher Syndrome
Figure 14. Global Ophthalmology Disorders Drug Market: Usher Syndrome (2017-2022) & ($ Millions)
Figure 15. Ophthalmology Disorders Drug in Retinitis Pigmentosa (Retinitis)
Figure 16. Global Ophthalmology Disorders Drug Market: Retinitis Pigmentosa (Retinitis) (2017-2022) & ($ Millions)
Figure 17. Global Ophthalmology Disorders Drug Market Size Market Share by Application in 2021
Figure 18. Global Ophthalmology Disorders Drug Revenue Market Share by Player in 2021
Figure 19. Global Ophthalmology Disorders Drug Market Size Market Share by Regions (2017-2022)
Figure 20. Americas Ophthalmology Disorders Drug Market Size 2017-2022 ($ Millions)
Figure 21. APAC Ophthalmology Disorders Drug Market Size 2017-2022 ($ Millions)
Figure 22. Europe Ophthalmology Disorders Drug Market Size 2017-2022 ($ Millions)
Figure 23. Middle East & Africa Ophthalmology Disorders Drug Market Size 2017-2022 ($ Millions)
Figure 24. Americas Ophthalmology Disorders Drug Value Market Share by Country in 2021
Figure 25. Americas Ophthalmology Disorders Drug Consumption Market Share by Type in 2021
Figure 26. Americas Ophthalmology Disorders Drug Market Size Market Share by Application in 2021
Figure 27. United States Ophthalmology Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 28. Canada Ophthalmology Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 29. Mexico Ophthalmology Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 30. Brazil Ophthalmology Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 31. APAC Ophthalmology Disorders Drug Market Size Market Share by Region in 2021
Figure 32. APAC Ophthalmology Disorders Drug Market Size Market Share by Application in 2021
Figure 33. China Ophthalmology Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 34. Japan Ophthalmology Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 35. Korea Ophthalmology Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 36. Southeast Asia Ophthalmology Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 37. India Ophthalmology Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 38. Australia Ophthalmology Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 39. Europe Ophthalmology Disorders Drug Market Size Market Share by Country in 2021
Figure 40. Europe Ophthalmology Disorders Drug Market Size Market Share by Type in 2021
Figure 41. Europe Ophthalmology Disorders Drug Market Size Market Share by Application in 2021
Figure 42. Germany Ophthalmology Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 43. France Ophthalmology Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 44. UK Ophthalmology Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 45. Italy Ophthalmology Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 46. Russia Ophthalmology Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 47. Middle East & Africa Ophthalmology Disorders Drug Market Size Market Share by Region in 2021
Figure 48. Middle East & Africa Ophthalmology Disorders Drug Market Size Market Share by Type in 2021
Figure 49. Middle East & Africa Ophthalmology Disorders Drug Market Size Market Share by Application in 2021
Figure 50. Egypt Ophthalmology Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 51. South Africa Ophthalmology Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 52. Israel Ophthalmology Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 53. Turkey Ophthalmology Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 54. GCC Country Ophthalmology Disorders Drug Market Size Growth 2017-2022 ($ Millions)
Figure 55. Americas Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 56. APAC Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 57. Europe Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 58. Middle East & Africa Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 59. United States Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 60. Canada Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 61. Mexico Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 62. Brazil Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 63. China Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 64. Japan Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 65. Korea Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 66. Southeast Asia Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 67. India Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 68. Australia Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 69. Germany Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 70. France Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 71. UK Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 72. Italy Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 73. Russia Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 74. Spain Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 75. Egypt Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 76. South Africa Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 77. Israel Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 78. Turkey Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
Figure 79. GCC Countries Ophthalmology Disorders Drug Market Size 2023-2028 ($ Millions)
